Pharmacy Continence Care - Bladder and Bowel Website
Pharmacy Continence Care - Bladder and Bowel Website
Pharmacy Continence Care - Bladder and Bowel Website
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
4.2.7 Changes in pharmacy behaviour<br />
Reasons for participation in trial<br />
The reasons given for participation in the PCCP were largely unchanged between the<br />
pharmacy entry <strong>and</strong> exit interviews. The main reason given for participation (around 90 per<br />
cent of sample) was to “provide for taking a bigger role in health advice”.<br />
A significantly higher proportion – 60 per cent – of pharmacies believed that this reason was<br />
a very strong influence after the PCCP trial compared with before the trial, demonstrating<br />
that the health advisory role was taken more seriously after the trial. The other finding of<br />
interest is that over 80 per cent of participants, compared with 66 per cent before the trial,<br />
thought that access to the resource materials had been a significant motivation to participate<br />
in the trial, demonstrating a positive view about, <strong>and</strong> impact of, the materials provided.<br />
Changes in pharmacy behaviour<br />
The survey results demonstrate that pharmacies made effective use of the PCCP materials<br />
provided. It is striking that all pharmacies in the trial who responded made use of the<br />
resource kit provided, with 85 per cent displaying the counter-talker <strong>and</strong> 78 per cent<br />
reserving separate space for conversations with the public about incontinence. The provision<br />
of ‘BB’ stickers was less used, by 66 per cent of respondents – <strong>and</strong> only a proportion of<br />
these pharmacies (again two thirds) ordered additional stickers. A caveat should be issued<br />
here – only two-thirds (32 out of 49) of the sample of pharmacies responded in the exit<br />
survey, <strong>and</strong> hence there is a potential for self-selection bias (i.e., only the most positive<br />
pharmacies responded to the exit questionnaire).<br />
Promotion of continence products<br />
The initial survey showed that under a quarter of community pharmacies surveyed spend<br />
anything at all on promoting the provision of incontinence products (special displays,<br />
storage, staff time etc.) <strong>and</strong> only 10 per cent of those sampled spent over $100 per month<br />
over the last year. There was a very similar finding in respect of staff training <strong>and</strong> locating<br />
information on incontinence – less than a quarter of pharmacies reported any expenditure on<br />
this activity, suggesting that without the PCCP, many community pharmacies would continue<br />
to ignore continence as an issue.<br />
Encouragingly, initial <strong>and</strong> exit pharmacy survey answers reveal that whilst expenditure on<br />
promoting <strong>and</strong> displaying continence products did not increase significantly (under 10 per<br />
cent of the exit survey sample reported spending $100 or over in the previous month in<br />
either survey), double the proportion of pharmacies (56 per cent vs. 28 per cent) reported<br />
some spending on displays, promotions etc. in the previous month. This demonstrates that<br />
increased awareness of incontinence was matched by greater visibility of incontinence<br />
products in the participating pharmacy.<br />
Provision of incontinence advice<br />
The results are not conclusive but seem to show an increase after the trial in the proportion<br />
(from 50 per cent to 75 per cent) of pharmacists providing more than one to two hours per<br />
week advice <strong>and</strong> a reduction of those providing little or no advice (under one hour per<br />
week). Conversely, a lower percentage of pharmacy assistants provided more than two<br />
hours a week of advice, suggesting some focusing on pharmacists to provide (possibly<br />
higher quality) advice.<br />
Final Report<br />
36<br />
NOVA Public Policy<br />
<strong>Pharmacy</strong> <strong>Continence</strong> <strong>Care</strong> Project